CARDIOVASCULAR [bdsy]
Response [orga]
Incretin [aapp, horm, phsu]
Based [ftcn]
therapy [ftcn]
New medications [phsu]
therapy [ftcn]
Diabetes [dsyn]
CARDIOVASCULAR [bdsy]
endpoints [qlco]
newly [idcn]
Incretin [aapp, horm, phsu]
Based [ftcn]
Medications [phsu]
GLP-1 Analogue [chvf]
DPP-4 Inhibitors [moft]
Known [qlco]
Metabolic Control [moft]
Receptors [aapp, rcpt]
GLP-1 [aapp]
Pancreatic [bpoc]
Tissue [tisu]
Including [ftcn]
Heart [bpoc]
Arteries [bpoc]
Question [inpr]
Incretins [aapp, horm, phsu]
Direct [qlco]
Cardia [blor]
Vascular System [bdsy]
glucose effect [genf]
lowering [spco]
experiments [resa]
GLP-1 [aapp]
effects [qlco]
Various [irda]
Able [orga]
GLP-1 [aapp]
Endothelial [tisu]
function [phsf]
GLP-1 receptor [aapp, rcpt]
Discover [acty]
Smooth muscle (tissue) [tisu]
Endothelial [tisu]
Call [menp]
GLP-1 [aapp]
Flow [npop]
mediated [socb]
Vasodilatation [phsf]
In Vitro [inpr]
GLP-1 [aapp]
GLP-1 [aapp]
Amide [orch]
effects [qlco]
Alteration [idcn]
Glucose [bacs, carb, phsu]
Patients [podg]
Myocardial Infarction [dsyn]
Severe [qlco]
Ventricular Dysfunction, Left [patf]
infusions [topp]
GLP-1 [aapp]
Able [orga]
regional [spco]
Global [spco]
function [phsf]
Following [tmco]
Successful [qlco]
Angioplasty [topp]
Cardiovascular disease [dsyn]
Highest [qlco]
Mortality [qnco]
People [popg]
Diabetes [dsyn]
Mechanisms [ftcn]
therapy [ftcn]
GLP-1 [aapp]
GLP-1 Analogue [chvf]
DPP-4 Inhibitors [moft]
Relevance [qlco]
Prognoses [hlca]
Patients [podg]
